A medicament for the prevention or treatment of an intraocular angiogenic disease that is proliferative retinopathy, retinal vein occlusion, retinal artery occlusion or age-related macular degeneration, which comprises an angiotensin II receptor antagonist that is a pharmacologically acceptable ester of 4-(1-hydroxy-1-methylethyl)-2-propyl-1-[2ʹ-(1H-tetrazol-5-yl)biphenyl-4-ylmethyl]imidazole-5-carboxylic acid or a pharmacologically acceptable salt thereof, as its active ingredient.
